Later Response to Corticosteroids in Adults With Primary Focal Segmental Glomerular Sclerosis Is Associated With Favorable Outcomes

INTRODUCTION: Guidelines advise initial therapy with corticosteroids (CSs) in patients with presumed primary focal segmental glomerular sclerosis (pFSGS). Many patients do not achieve complete remission (CR) after 8 or 16 weeks. Although these patients are considered steroid resistant, clinical outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Rood, Ilse M., Bavinck, Aernoud, Lipska-Ziętkiewicz, Beata S., Lugtenberg, Dorien, Schaefer, Franz, Deegens, Jeroen K.J., Wetzels, Jack F.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720814/
https://www.ncbi.nlm.nih.gov/pubmed/35005317
http://dx.doi.org/10.1016/j.ekir.2021.10.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720814/
https://www.ncbi.nlm.nih.gov/pubmed/35005317
http://dx.doi.org/10.1016/j.ekir.2021.10.016

Ejemplares similares